Gerresheimer AG Overview
Pro stress-test →Gerresheimer specializes in producing glass and plastic containers, including vials, ampoules, and cartridges, which are crucial for delivering drugs and vaccines safely to patients worldwide. The company's offerings extend to complex drug delivery devices like insulin pens and inhalers. This strategic alignment positions it well amid growing global health needs and an aging population, driving steady demand for its high-margin products.
Strategic Profile
Pro stress-test →Gerresheimer's business model thrives on close partnerships with pharmaceutical giants, crafting tailor-made solutions for diverse therapeutic areas. A comprehensive transformation program is being implemented, including cost reductions, operational improvements, and a new segmentation starting in 2026. The company is preparing to carve out and sell the Moulded Glass business, with new leadership in place.
Competitive Landscape
Pro stress-test →The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Primary competitors include SCHOTT Pharma and Stevanato Group in pharmaceutical packaging. Gerresheimer maintains competitive advantages through integrated drug delivery solutions, but faces pricing pressures and market consolidation.
Industry Context
Gerresheimer AG operates in Healthcare Packaging & Drug Delivery Devices.
Key facts
Founded: 1864 · Headquarters: Düsseldorf, Germany · Employees: 12,142 · Revenue: €2.04B (2024)